TORONTO, ON --
Sept. 24, 2018 -- InvestorsHub NewsWire -- Maricann Group
Inc. (CSE: MARI) (OTCQB: MRRCF)
(FRANKFURT:75M) (“Maricann” or the
"Company") today announced that it intends to change its name to
Wayland Group Corp. In the interim, the Company expects to commence
operating through its subsidiaries under the business name “Wayland
Group”. In anticipation of the proposed name change, the Company
has also announced that, effective September 25,
2018, its ticker symbol on the Canadian Securities
Exchange will be “WAYL”.
The corporate renaming to
Wayland Group supports the Company’s ongoing global expansion and
development of both medical and non-medical consumer brands. The
Company’s leadership team remains committed to foundational values
of superior quality and world-class innovation at this milestone
for the organization.
“Our roots in medical
cannabis establish us as leaders on the world stage and the
tremendous work our team has done building our production
facilities, entering into provincial supply agreements and
cultivating European partnerships has put us in this extraordinary
position that we’re in today,” said Ben Ward, CEO of the Company.
“The new name reflects the more expansive portfolio that we’ve
built and the direction that we’re heading as a global cannabis
company.”
The Company’s innovations
include their purpose-built, high-tech production facilities in
Langton, Ontario and licensing of product technologies such
as VESIsorb®, a cannabidiol
absorption technology. The Company’s recently launched recreational
cannabis brand, Kiwi solidifies its customer needs-driven
philosophy.
The proposed change in name
to Wayland Group Corp. is subject to certain conditions, including
approval of the Company’s shareholders, which the Company intends
to seek at its next meeting of shareholders expected to be held
later this year.
About Maricann
Group Inc.
The Company is a vertically integrated producer and distributor of
cannabis currently for medical purposes. The Company plans to
produce and distribute recreational cannabis products in Canada
once legalization occurs. Maricann was founded as Maricann in 2013
and is based in Burlington, Ontario, Canada and Munich, Germany.
The Company has production facilities in Langton, Ontario where it
operates a medicinal cannabis cultivation, extraction, formulation
and distribution business under federal licence from the Government
of Canada. Maricann also has production operations in Dresden,
Saxony, Germany and Regensdorf, Switzerland and is undertaking an
expansion of its cultivation and support facilities in Canada in a
942,000 sq. ft. (87,515 sq. m) facility and will continue to pursue
new opportunities in Europe.
Forward Looking
Statements
This news release includes forward-looking information and
statements, which may include, but are not limited to, information
and statements regarding or inferring the future business,
operations, financial performance, prospects, and other plans,
intentions, expectations, estimates, and beliefs of the Company.
Such statements include statements regarding the anticipated
timeline for holding the Company’s next meeting of shareholders and
other matters in connection with its proposed name change and the
approval thereof and the use of the Wayland Group business name.
Such statements may not prove to be accurate if the Company does
not receive the require approvals for its proposed name change.
Forward-looking information and statements involve and are subject
to assumptions and known and unknown risks, uncertainties, and
other factors which may cause actual events, results, performance,
or achievements of the Company to be materially different from
future events, results, performance, and achievements expressed or
implied by forward-looking information and statements herein.
Although the Company believes that any forward-looking information
and statements herein are reasonable, in light of the use of
assumptions and the significant risks and uncertainties inherent in
such information and statements, there can be no assurance that any
such forward-looking information and statements will prove to be
accurate, including receipt of shareholder approval for the
proposed name change and the satisfaction of all other conditions
to the name change and use of the Wayland Group business name, and
accordingly readers are advised to rely on their own evaluation of
such risks and uncertainties and should not place undue reliance
upon such forward-looking information and statements. Any
forward-looking information and statements herein are made as of
the date hereof, and except as required by applicable laws, the
Company assumes no obligation and disclaims any intention to update
or revise any forward-looking information and statements herein or
to update the reasons that actual events or results could or do
differ from those projected in any forward looking information and
statements herein, whether as a result of new information, future
events or results, or otherwise, except as required by applicable
laws.
CONTACT
INFORMATION
Investor Relations
Graham Farrell
VP, Communications
graham@maricann.com
647-643-7665
Corporate Headquarters (Canada)
Maricann Group Inc. (Toronto)
845 Harrington Court, Unit 3
Burlington Ontario L7N 3P3
Canada
289-288-6274
European Headquarters (Germany)
Maricann GmbH
Thierschstrasse 3, 80538 Munchen, Deutschland